These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 39044509)

  • 1. Economic Impact of Progression from Mild Cognitive Impairment to Alzheimer Disease in the United States.
    Frech FH; Li G; Juday T; Ding Y; Mattke S; Khachaturian A; Rosenberg AS; Ndiba-Markey C; Rava A; Batrla R; De Santi S; Hampel H
    J Prev Alzheimers Dis; 2024; 11(4):983-991. PubMed ID: 39044509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare Expenditures of Individuals with Alzheimer's Disease and Related Dementias or Mild Cognitive Impairment Before and After Diagnosis.
    Lin PJ; Zhong Y; Fillit HM; Chen E; Neumann PJ
    J Am Geriatr Soc; 2016 Aug; 64(8):1549-57. PubMed ID: 27295430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic Burden of Irritable Bowel Syndrome with Diarrhea: Retrospective Analysis of a U.S. Commercially Insured Population.
    Buono JL; Mathur K; Averitt AJ; Andrae DA
    J Manag Care Spec Pharm; 2017 Apr; 23(4):453-460. PubMed ID: 28345443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs of Early Stage Alzheimer's Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1.
    Robinson RL; Rentz DM; Andrews JS; Zagar A; Kim Y; Bruemmer V; Schwartz RL; Ye W; Fillit HM
    J Alzheimers Dis; 2020; 75(2):437-450. PubMed ID: 32250304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing emergency department use among individuals with varying levels of cognitive impairment.
    Green RK; Shah MN; Clark LR; Batt RJ; Chin NA; Patterson BW
    BMC Geriatr; 2022 May; 22(1):382. PubMed ID: 35501721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Health Care Utilization in Dementia Subtypes Before Diagnosis.
    Albrecht JS; Hanna M; Kim D; Perfetto EM
    Alzheimer Dis Assoc Disord; 2018; 32(4):326-332. PubMed ID: 30299276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Care Utilization, Care Satisfaction, and Health Status for Medicare Advantage and Traditional Medicare Beneficiaries With and Without Alzheimer Disease and Related Dementias.
    Park S; White L; Fishman P; Larson EB; Coe NB
    JAMA Netw Open; 2020 Mar; 3(3):e201809. PubMed ID: 32227181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonoperative care to manage sacroiliac joint disruption and degenerative sacroiliitis: high costs and medical resource utilization in the United States Medicare population.
    Ackerman SJ; Polly DW; Knight T; Holt T; Cummings J
    J Neurosurg Spine; 2014 Apr; 20(4):354-63. PubMed ID: 24527824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cycling Through Migraine Preventive Treatments: Implications for All-Cause Total Direct Costs and Disease-Specific Costs.
    Ford JH; Schroeder K; Nyhuis AW; Foster SA; Aurora SK
    J Manag Care Spec Pharm; 2019 Jan; 25(1):46-59. PubMed ID: 30044691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease.
    Mucha L; Shaohung S; Cuffel B; McRae T; Mark TL; Del Valle M
    J Manag Care Pharm; 2008 Jun; 14(5):451-61. PubMed ID: 18597574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health care utilization patterns and costs for patients with hidradenitis suppurativa.
    Kirby JS; Miller JJ; Adams DR; Leslie D
    JAMA Dermatol; 2014 Sep; 150(9):937-44. PubMed ID: 24908260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
    Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
    J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health Care Burden Associated with Outpatient Opioid Use Following Inpatient or Outpatient Surgery.
    Brummett CM; England C; Evans-Shields J; Kong AM; Lew CR; Henriques C; Zimmerman NM; Pawasauskas J; Oderda G
    J Manag Care Spec Pharm; 2019 Sep; 25(9):973-983. PubMed ID: 31313621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health Care Costs of Alzheimer's and Related Dementias Within a Medicare Managed Care Provider.
    Fishman PA; White L; Ingraham B; Park S; Larson EB; Crane P; Coe NB
    Med Care; 2020 Sep; 58(9):833-841. PubMed ID: 32826748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-World Economic Outcomes During Time on Treatment Among Patients Who Initiated Sunitinib or Pazopanib as First Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Analysis of Medicare Claims Data.
    Vogelzang NJ; Pal SK; Ghate SR; Li N; Swallow E; Peeples M; Zichlin ML; Meiselbach MK; Perez JR; Agarwal N
    J Manag Care Spec Pharm; 2018 Jun; 24(6):525-533. PubMed ID: 29799328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Care Resource Utilization and Costs for Patients with Tardive Dyskinesia.
    Carroll B; Irwin DE
    J Manag Care Spec Pharm; 2019 Jul; 25(7):810-816. PubMed ID: 31232207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications.
    Axon DR; Vaffis S; Chinthammit C; Lott BE; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1529-1537. PubMed ID: 33251989
    [No Abstract]   [Full Text] [Related]  

  • 19. Costs and health care resource utilization among Medicare beneficiaries diagnosed with chronic lymphocytic leukemia.
    Lee TY; Johnson A; Cooke CE; Yared JA; Summers A; Yang K; Liu S; Tang B; Onukwugha E
    J Manag Care Spec Pharm; 2024 May; 30(5):430-440. PubMed ID: 38701030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.